Evidence map›Paper›PMID 27595922›Full record

ArticleStem cells and development2016

Contribution of Caudal Müllerian Duct Mesenchyme to Prostate Development.

Hannah Brechka, Erin M McAuley, Sophia M Lamperis, Gladell P Paner, Donald J Vander Griend

Abstract read
In one paragraph

Article in Stem cells and development, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Specific deletion of LKB1/Proceedings of the National Academy of Sciences of the United States of America · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Hannah Brechka1 The Committee on Cancer Biology, The University of Chicago , Chicago, Illinois.
Erin M McAuley2 The Committee on Molecular Pathology and Molecular Medicine, The University of Chicago , Chicago, Illinois.
Sophia M Lamperis3 Department of Surgery, Section of Urology, The University of Chicago , Chicago, Illinois.
Gladell P Paner4 Department of Pathology, The University of Chicago , Chicago, Illinois.
Donald J Vander Griend1 The Committee on Cancer Biology, The University of Chicago , Chicago, Illinois.

Funding

Molecular And Cellular Biology Training ProgramT32GM007183 · NIGMS · UNIVERSITY OF CHICAGO · PI GLICK, BENJAMIN S, RICE, PHOEBE A · 1985 to 2021
$23.9M
Multi-Disciplinary Training Grant in Cancer ResearchT32CA009594 · NCI · UNIVERSITY OF CHICAGO · PI KAY F MACLEOD, Scott A. Oakes · 1989 to 2026
$11.5M
Function of the Stem Cell Transcription Factor Sox2 in Prostate CancerR01CA178431 · NCI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI VANDER GRIEND, DONALD JAMES · 2014 to 2018
$1.9M
NCI NIH HHS R01 CA178431NCI NIH HHS T32 CA009594NIGMS NIH HHS T32 GM007183
6 · The paper itself

Abstract

A fundamental understanding of prostate development and tissue homeostasis has the high potential to reveal mechanisms for prostate disease initiation and identify novel therapeutic approaches for disease prevention and treatment. Our current understanding of prostate lineage specification stems from the use of developmental model systems that rely upon the embryonic preprostatic urogenital sinus mesenchyme to induce the formation of mature prostate epithelial cells. It is unclear, however, how the urogenital sinus epithelium can derive both adult urethral glands and prostate epithelia. Furthermore, the vast disparity in disease initiation between these two glands highlights key developmental factors that predispose prostate epithelia to hyperplasia and cancer. In this study we demonstrate that the caudal Müllerian duct mesenchyme (CMDM) drives prostate epithelial differentiation and is a key determinant in cell lineage specification between urethral glands and prostate epithelia. Utilizing both human embryonic stem cells and mouse embryonic tissues, we document that the CMDM is capable of inducing the specification of androgen receptor, prostate-specific antigen, NKX3.1, and Hoxb13-positive prostate epithelial cells. These results help to explain key developmental differences between prostate and urethral gland differentiation, and implicate factors secreted by the caudal Müllerian duct as novel targets for prostate disease prevention and treatment.

Indexed as

OrganogenesisAnimalsCell DifferentiationCell LineCell LineageEpitheliumHuman Embryonic Stem CellsHumansMaleMesodermMice, Inbred C57BLModels, BiologicalMullerian DuctsProstateTranscription FactorsUrethraTranscription Factorsandrogen receptorHOXB13Müllerian ductNKX3.1prostate

Identifiers

PMID27595922
PMCPMC5105354

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.